We are live on
!
Find out more
BCM
Bayesian Capital Management Portfolio holdings
AUM
$156M
1-Year Est. Return
14.89%
This Fund
S&P 500
This Quarter
Est. Return
+23.96%
1 Year Est. Return
+14.89%
3 Year Est. Return
+106.87%
5 Year Est. Return
+133.82%
10 Year Est. Return
+1,146.09%
AUM
$521M
AUM Growth
+$32.6M
(+6.7%)
Cap. Flow
-$31.4M
Cap. Flow
% of AUM
-6.03%
Top 10 Holdings %
Top 10 Hldgs %
11.92%
Holding
876
New
284
Increased
86
Reduced
155
Closed
349
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$7.2M |
| 2 |
Alibaba
BABA
|
+$7.15M |
| 3 |
Accenture
ACN
|
+$6.96M |
| 4 |
FL
Foot Locker
FL
|
+$6.31M |
| 5 |
Procter & Gamble
PG
|
+$4.82M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$7.91M |
| 2 |
Nike
NKE
|
+$7.89M |
| 3 |
Apple
AAPL
|
+$6.97M |
| 4 |
Mondelez International
MDLZ
|
+$5.33M |
| 5 |
Danaher
DHR
|
+$4.12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.29% |
| 2 | Consumer Discretionary | 21.31% |
| 3 | Healthcare | 12.92% |
| 4 | Industrials | 9.02% |
| 5 | Consumer Staples | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Labcorp
LH
$27.3B
| $382K | 0.07% |
+2,910
| New | +$358K |
|
352
Pacira BioSciences
PCRX
$1.03B
| $381K | 0.07% |
+10,000
| New | +$390K |
|
|
MTOR
353
DELISTED
MERITOR, Inc.
MTOR
| $380K | 0.07% |
18,690
-1,000
| -5% | -$20.4K |
|
354
Bilibili
BILI
$7.02B
| $377K | 0.07% |
19,900
+1,300
| +7% | +$22.8K |
|
355
Canadian Natural Resources
CNQ
$103B
| $366K | 0.07% |
+27,159
| New | +$361K |
|
356
Tenaris
TS
$27.4B
| $362K | 0.07% |
+12,811
| New | +$331K |
|
357
Werner Enterprises
WERN
$2.31B
| $359K | 0.07% |
10,500
-10,100
| -49% | -$337K |
|
358
Diodes
DIOD
$4.18B
| $357K | 0.07% |
10,300
-800
| -7% | -$28.7K |
|
359
Direxion Daily Gold Miners Index Bear 2X ETF
DUST
$66.5M
| $354K | 0.07% |
+8
| New | +$399K |
|
360
Criteo S.A.
CRTO
$845M
| $349K | 0.07% |
+17,400
| New | +$443K |
|
|
PLAN
361
DELISTED
Anaplan, Inc.
PLAN
| $346K | 0.07% |
+8,800
| New | +$296K |
|
362
Standard BioTools
LAB
$256M
| $344K | 0.07% |
+25,870
| New | +$273K |
|
363
JELD-WEN Holding
JELD
$189M
| $341K | 0.07% |
+19,319
| New | +$348K |
|
|
CONN
364
DELISTED
Conn's Inc.
CONN
| $341K | 0.07% |
+14,900
| New | +$321K |
|
|
ENDP
365
DELISTED
Endo International plc
ENDP
| $340K | 0.07% |
42,314
-7,400
| -15% | -$69.6K |
|
366
CRISPR Therapeutics
CRSP
$5.74B
| $339K | 0.07% |
+9,500
| New | +$328K |
|
367
HealthEquity
HQY
$7.72B
| $337K | 0.06% |
+4,558
| New | +$320K |
|
368
Vishay Intertechnology
VSH
$4.87B
| $336K | 0.06% |
+18,217
| New | +$364K |
|
|
GWPH
369
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $335K | 0.06% |
+1,987
| New | +$296K |
|
|
NVTA
370
DELISTED
Invitae Corporation
NVTA
| $334K | 0.06% |
14,261
-6,039
| -30% | -$107K |
|
371
FNB Corp
FNB
$6.58B
| $329K | 0.06% |
31,000
-5,000
| -14% | -$57.5K |
|
372
Lincoln National
LNC
$8.33B
| $325K | 0.06% |
+5,538
| New | +$328K |
|
373
Skywest
SKYW
$3.84B
| $323K | 0.06% |
5,945
-3,272
| -35% | -$168K |
|
|
MOMO
374
Hello Group
MOMO
$844M
| $322K | 0.06% |
+8,420
| New | +$269K |
|
|
NLSN
375
DELISTED
Nielsen Holdings plc
NLSN
| $320K | 0.06% |
+13,510
| New | +$350K |
|
Similar funds
MCM
MFG
AFW
ADBIC
HSM
FWM
PIA
CCP
Bayesian Capital Management's Q1 2019 Portfolio in Review
As of Q1 2019, Bayesian Capital Management held 876 positions worth $521M, up 6.7% from $488M the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Bayesian Capital Management withdrew a net $31.4M in Q1 2019, closing 349 positions and reducing 155 holdings. Its most notable exit was Nike, an estimated $7.89M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Bayesian Capital Management opened a new position in Micron Technology worth $7.71M.
- Bayesian Capital Management's largest Q1 2019 buy was Micron Technology: 186,500 shares worth $7.71M.
- Bayesian Capital Management added most to Procter & Gamble in Q1 2019, an estimated $4.82M increase.
- Bayesian Capital Management's biggest Q1 2019 reduction was Microsoft, cutting an estimated $7.91M.
- Bayesian Capital Management fully exited Nike in Q1 2019, selling an estimated $7.89M.
- Bayesian Capital Management's ten largest holdings make up 12% of its $521M portfolio in Q1 2019.
- Bayesian Capital Management opened 284 new positions and closed 349 in Q1 2019.
- Bayesian Capital Management's portfolio value rose 6.7% quarter-over-quarter to $521M.
Based on Bayesian Capital Management's 13F filing for Q1 2019, filed 14 May 2019.